barium has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cano-Abad, MF; Gandía, L; García, AG; Hernández-Guijo, JM; López, MG; Sánchez-García, P; Zapater, P | 1 |
| Murer, MG; Pomata, P; Rela, L; Rodriguez, MJ; Sanchez, G | 1 |
2 other study(ies) available for barium and oxidopamine
| Article | Year |
|---|---|
Effects of the neuroprotectant lubeluzole on the cytotoxic actions of veratridine, barium, ouabain and 6-hydroxydopamine in chromaffin cells.
Topics: Adrenal Glands; Animals; Barium; Calcium; Cattle; Chromaffin Cells; Cytosol; Neuroprotective Agents; Ouabain; Oxidopamine; Penfluridol; Piperidines; Sodium; Thiazoles; Veratridine | 1998 |
Reduction of an afterhyperpolarization current increases excitability in striatal cholinergic interneurons in rat parkinsonism.
Topics: Acetylcholine; Action Potentials; Analysis of Variance; Animals; Anthracenes; Apamin; Ascorbic Acid; Barium; Computer Simulation; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Indoles; Interneurons; Male; Models, Neurological; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2011 |